A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
08/1999
08/19/1999	CA2320431A1 Targeting of genetic vaccine vectors
08/19/1999	CA2320383A1 Hiv chemokines
08/19/1999	CA2320302A1 Combination of a nucleic acid and a vasoactive agent for enhanced gene delivery
08/19/1999	CA2320226A1 Methods and compositions for modulating leptin activity
08/19/1999	CA2319782A1 Retinoblastoma protein complexes and retinoblastoma interacting proteins
08/19/1999	CA2319492A1 Novel dimerizing agents, their production and use
08/19/1999	CA2319212A1 Methods for purified aav vector production
08/19/1999	CA2319134A1 Novel means and methods for the preparation and activation of nucleoside and nucleotide based drugs
08/18/1999	EP0936270A2 Serin protease from prostate
08/18/1999	EP0935676A2 Method of identifying cytochrome p450
08/18/1999	EP0935664A2 New systems for regulating genetic expression
08/18/1999	EP0935663A2 Multi-functional chimeric hematopoietic receptor agonists
08/18/1999	EP0935661A1 Recombinant kynurenine-3-hydroxylase enzyme and process for its preparation
08/18/1999	EP0935659A1 Compositions and methods for treating intracellular diseases
08/18/1999	EP0935657A2 Modified glucocorticoid receptors, glucocorticoid receptors/progesterone receptors hybrids
08/18/1999	EP0935656A1 Hedgehog interacting proteins and uses related thereto
08/18/1999	EP0935654A1 Fibroblast growth factor homologous factor-3 (fhf-3) and methods of use
08/18/1999	EP0935653A1 Nucleic acid molecules coding for tumor suppressor proteins and methods for their isolation
08/18/1999	EP0935651A2 THERAPY FOR $g(a)-GALACTOSIDASE A DEFICIENCY
08/18/1999	EP0935648A1 Improved adenovirus vectors
08/18/1999	EP0935471A1 Mononuclear phagocytes in therapeutic drug delivery
08/18/1999	EP0935470A1 Method for treating allergic lung disease
08/18/1999	EP0935458A1 Compositions containing at least one nucleic acid
08/18/1999	EP0935415A1 Methods for delivering compounds into a cell
08/18/1999	CN1226174A Use of proteinase inhibitors for prevention or reduction of bone resorption
08/17/1999	US5939538 Methods and compositions for inhibiting HIV infection of cells by cleaving HIV co-receptor RNA
08/17/1999	US5939536 Methods for purifying cystic fibrosis transmembrane conductance regulation
08/17/1999	US5939401 Cationic amphiphile compositions for intracellular delivery of therapeutic molecules
08/17/1999	US5939400 DNA vaccination for induction of suppressive T cell response
08/17/1999	US5939391 Hemoglobin alpha chain peptide fragments useful for inhibiting stem cell proliferation
08/17/1999	US5939321 Mammalian tolloid-like gene and protein
08/17/1999	US5939298 Isolated polynucleotide segment having amino acid sequence homology to a known haemophilus influenzae phenylalanyl trna synthetase (alpha-subunit)protein; can be used to screen for antibacterial compounds
08/17/1999	US5939284 Protein phosphatase 1 binding protein, R5
08/17/1999	US5939271 Recombinant nucleic acid molecule coding for polypeptide which has cell and neuron chemotactic functions; diagnosis, gene therapy, immunogens
08/17/1999	US5939064 Bordetella bronchiseptica vaccine
08/13/1999	CA2226919A1 Neuroserpin
08/12/1999	WO1999040225A1 Immediate early genes and methods of use therefor
08/12/1999	WO1999040214A2 Nucleic acid delivery vehicles
08/12/1999	WO1999040212A2 Bacteriophage vectors generated by bacteriophage/plasmid recombination
08/12/1999	WO1999040207A1 HUMAN HEPARANASE POLYPEPTIDE AND cDNA
08/12/1999	WO1999040201A1 Protein
08/12/1999	WO1999040197A2 Variants of the angiogenic factor vascular endothelial cell growth factor: vegf
08/12/1999	WO1999040192A1 Human receptor gpr14, and a method of finding agonist and antagonist to human and rat gpr14
08/12/1999	WO1999040189A2 Cdnas encoding secreted proteins
08/12/1999	WO1999040188A2 Tumor-associated antigen derivatives from the mage family, and nucleic acid sequences encoding them, used for the preparation of fusion proteins and of compositions for vaccinations
08/12/1999	WO1999040187A1 Nucleic acids provided for modulating cellular activation
08/12/1999	WO1999040186A1 Optimized antisense oligonucleotides complementary to dna methyltransferase sequences
08/12/1999	WO1999040184A1 Dendritic enriched secreted lymphocyte activation molecule
08/12/1999	WO1999040181A1 Growth differentiation factor-8
08/12/1999	WO1999040180A2 Expanded and genetically modified populations of human hematopoietic stem cells
08/12/1999	WO1999040111A1 The aiolos gene
08/12/1999	WO1999040110A1 Breast cancer resistance protein (bcrp) and the dna which encodes it
08/12/1999	WO1999040109A2 Recombinant mistletoe lectines
08/12/1999	WO1999040100A1 45 human secreted proteins
08/12/1999	WO1999039744A1 Compositions and methods for polynucleotide delivery
08/12/1999	WO1999039742A1 Liposome fusion and delivery vehicle
08/12/1999	WO1999039741A2 Systemic delivery of serum stable plasmid lipid particles for cancer therapy
08/12/1999	WO1999039740A2 Sensitizing cells to compounds using lipid-mediated gene and compound delivery
08/12/1999	WO1999039738A1 Targeted delivery of biologically active media
08/12/1999	WO1999039735A1 Live vaccine for human immunodeficiency virus
08/12/1999	WO1999039734A1 Adenovirus vector containing a heterologous peptide epitope in the hi loop of the fiber knob
08/12/1999	WO1999039733A1 Delivery method for recombinant raccoon poxvirus
08/12/1999	WO1999039724A1 Treatment of bony defects with osteoblast precursor cells
08/12/1999	WO1999031260A3 Regulatory sequences involved in pancreas-specific gene expression
08/12/1999	WO1999031230A3 Oligophrenin-1, its expression product, and the diagnostic and therapeutic applications thereof
08/12/1999	WO1999029884A3 Tgc method for inducting targeted somatic transgenesis
08/12/1999	WO1999028488A3 Pseudo-type retroviral vectors with modifiable surface capsid proteins
08/12/1999	WO1999027955A3 Treatment of established chronic infections and cancers
08/12/1999	WO1999027123A3 Modified sv40 viral vectors
08/12/1999	WO1999027093A3 The nip3 family of proteins
08/12/1999	WO1999025378A9 Immunoglobulin molecules having a synthetic variable region and modified specificity
08/12/1999	WO1999021875A9 Kcnq2 and kcnq3-potassium channel genes which are mutated in benign familial neonatal convulsions (bfnc) and other epilepsies
08/12/1999	WO1999018226A9 Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis
08/12/1999	WO1999018195A3 Methods and compositions for inducing tumor-specific cytotoxicity
08/12/1999	WO1999015684A8 Expression of genes in hematopoietic stem cells in hischaemic conditions
08/12/1999	WO1999002132A3 Use of submicron oil-in-water emulsions with dna vaccines
08/12/1999	WO1998057662A3 Therapeutic systems
08/12/1999	DE19838967A1 Suppressing proliferation, tumor formation and metastasis of CD30-positive cells by contact with specific binding agent, for treating tumors
08/12/1999	DE19805371A1 New semaphorin L proteins
08/12/1999	DE19805351A1 New human G-protein coupled receptor from brain tissue, used to treat nervous system disorders, e.g. Alzheimer's disease, eating disorders and as cerebral protectant
08/12/1999	DE19805334A1 Verfahren zur Entwicklung eines pharmazeutischen Wirkstoffes A method of developing a pharmaceutical active ingredient
08/12/1999	DE19804210A1 Rekombinante Mistellektine Recombinant mistletoe
08/12/1999	CA2327545A1 Adenovirus vector containing a heterologous peptide epitope in the hi loop of the fiber knob
08/12/1999	CA2325744A1 Liposome fusion and delivery vehicle
08/12/1999	CA2320625A1 45 human secreted proteins
08/12/1999	CA2320489A1 Live vaccine for human immunodeficiency virus
08/12/1999	CA2319664A1 Variants of the angiogenic factor vascular endothelial cell growth factor: vegf
08/12/1999	CA2319468A1 Sensitizing cells to compounds using lipid-mediated gene and compound delivery
08/12/1999	CA2319097A1 Dendritic enriched secreted lymphocyte activation molecule
08/12/1999	CA2319086A1 Optimized antisense oligonucleotides complementary to dna methyltransferase sequences
08/12/1999	CA2318981A1 Nucleic acid delivery vehicles
08/12/1999	CA2318919A1 Bacteriophage vectors generated by bacteriophage/plasmid recombination
08/12/1999	CA2318819A1 Expanded and genetically modified populations of human hematopoietic stem cells
08/12/1999	CA2316182A1 Cdnas encoding secreted proteins
08/11/1999	EP0935001A1 Novel vegf-like factors
08/11/1999	EP0934423A2 Aav-dna helper virus sequences
08/11/1999	EP0934422A2 Gene therapy for congestive heart failure
08/11/1999	EP0934416A1 Feline polynucleotide vaccine formula
08/11/1999	EP0934412A1 HUMAN THYMOSIN beta 15 GENE, PROTEIN AND USES THEREOF
08/11/1999	EP0934411A1 Compositions for treating anemia

1 ... 749 750 751 752 753 754 755 756 757 758 759 760 761 762 763 764 765 766 767 768 769 ... 870